Q3 2016 Holdings
Filed 2016-11-14 | 71 holdings | $109.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ishares TR(IBB) | NASDQ BIOTEC ETF | 464287556 | $27.1K | 93,730 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $30.5K | 496,434 | 0.0% |
| Ctrip COM Intl LTD | NOTE 1.250%10/1 | 22943FAD2 | $32.4K | $25,000,000 | 0.0% |
| Wellpoint Inc | NOTE 2.750%10/1 | 94973VBG1 | $32.7K | $18,500,000 | 0.0% |
| Clovis Oncology Inc | NOTE 2.500% 9/1 | 189464AB6 | $34.7K | $36,295,000 | 0.0% |
| Intel Corp(INTC) | COM | 458140100 | $35.1K | 930,004 | 0.0% |
| Makemytrip Limited Mauritius(MMYT) | SHS | V5633W109 | $39.6K | 1,794,024 | 0.0% |
| Ship Finance International L | NOTE 3.250% 2/0 | G81075AE6 | $43.7K | $40,500,000 | 0.0% |
| Novellus SYS Inc | NOTE 2.625% 5/1 | 670008AD3 | $56.5K | $20,193,000 | 0.1% |
| Goldman Sachs Group Inc(GS) | COM | 38141G104 | $69.0K | 427,558 | 0.1% |
| TAL ED Group | NOTE 2.500% 5/1 | 874080AB0 | $78.9K | $29,000,000 | 0.1% |
| Verisign Inc | SDCV 3.250% 8/1 | 92343EAD4 | $79.4K | $34,600,000 | 0.1% |
| Microchip Technology Inc | SDCV 2.125%12/1 | 595017AB0 | $82.4K | $31,764,000 | 0.1% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $317.0K | 4,781,800 | 0.3% |
| Axovant Sciences LTD | COM | G0750W104 | $1.1M | 75,000,000 | 1.0% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $5.1M | 722,233 | 4.7% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $5.2M | 170,000 | 4.8% |
| Antero RES Corp(AR) | COM | 03674X106 | $10.1M | 373,413 | 9.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $12.4M | 133,933 | 11.3% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $18.8M | 2,556,256 | 17.2% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $55.1M | 16,013,540 | 50.4% |